Prosight Management, LP Quant / Systematic

CIK: 0001617201 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value ($000): $136,405 (100.0% shares, 0.0% debt)

Holdings (31)

CIGNA CORPORATION 9.6%
Value ($000) $13,154 Shares 77,400 Est. Cost $169.03 Unrealized
MGNX MACROGENICS INC 9.4%
Value ($000) $12,772 Shares 618,515 Est. Cost $19.75 Unrealized +14.1%
ALLERGAN PLC 8.8%
Value ($000) $11,954 Shares 71,700 Est. Cost $163.58 Unrealized
TELIGENT INC NEW 8.4%
Value ($000) $11,505 Shares 3,325,000 Est. Cost $3.39 Unrealized
PIERIS PHARMACEUTICALS INC 5.1%
Value ($000) $6,895 Shares 1,360,000 Est. Cost $5.80 Unrealized
ATHENAHEALTH INC 4.8%
Value ($000) $6,555 Shares 41,193 Est. Cost $159.13 Unrealized
ARENA PHARMACEUTICALS INC 4.5%
Value ($000) $6,083 Shares 139,528 Est. Cost $40.06 Unrealized
CIDARA THERAPEUTICS INC 4.4%
Value ($000) $6,025 Shares 1,158,700 Est. Cost $6.80 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 4.1%
Value ($000) $5,631 Shares 439,900 Est. Cost $11.47 Unrealized +27.4%
BMRN BIOMARIN PHARMACEUTICAL INC 4.0%
Value ($000) $5,454 Shares 57,900 Est. Cost $85.82 Unrealized +2.0%
SHIRE PLC 4.0%
Value ($000) $5,402 Shares 32,000 Est. Cost $149.39 Unrealized
EIGER BIOPHARMACEUTICALS INC 3.9%
Value ($000) $5,349 Shares 438,422 Est. Cost $13.95 Unrealized
SIERRA ONCOLOGY INC 3.9%
Value ($000) $5,347 Shares 1,806,562 Est. Cost $2.07 Unrealized
KURA KURA ONCOLOGY INC 3.8%
Value ($000) $5,240 Shares 287,887 Est. Cost $16.94 Unrealized 0.0%
INTEC PHARMA LTD JERUSALEM 3.6%
Value ($000) $4,951 Shares 1,125,153 Est. Cost $4.40 Unrealized
ACHAOGEN INC 2.4%
Value ($000) $3,248 Shares 375,000 Est. Cost $11.04 Unrealized
MYLAN N V 2.1%
Value ($000) $2,920 Shares 80,800 Est. Cost $36.14 Unrealized
REATA PHARMACEUTICALS INC 2.1%
Value ($000) $2,906 Shares 83,094 Est. Cost $25.04 Unrealized
ASSEMBLY BIOSCIENCES INC 1.9%
Value ($000) $2,560 Shares 65,301 Est. Cost $39.20 Unrealized
SBRA SABRA HEALTH CARE REIT INC 1.6%
Value ($000) $2,149 Shares 98,906 Est. Cost $18.43 Unrealized
ESPR ESPERION THERAPEUTICS INC NE 1.4%
Value ($000) $1,912 Shares 48,800 Est. Cost $50.52 Unrealized 0.0%
PARATEK PHARMACEUTICALS INC 1.1%
Value ($000) $1,476 Shares 144,752 Est. Cost $17.90 Unrealized
NABRIVA THERAPEUTICS PLC 1.1%
Value ($000) $1,467 Shares 421,414 Est. Cost $4.92 Unrealized
CNC CENTENE CORP DEL 1.0%
Value ($000) $1,340 Shares 10,875 Est. Cost $48.44 Unrealized +19.0%
AQUINOX PHARMACEUTICALS INC 0.8%
Value ($000) $1,062 Shares 400,900 Est. Cost $2.65 Unrealized
KEZAR LIFE SCIENCES INC 0.5%
Value ($000) $721 Shares 41,691 Est. Cost $17.29 Unrealized
NOVELION THERAPEUTICS INC 0.5%
Value ($000) $716 Shares 194,663 Est. Cost $3.12 Unrealized
CIVITAS SOLUTIONS INC 0.4%
Value ($000) $568 Shares 34,649 Est. Cost $15.40 Unrealized
CLLS CELLECTIS S A 0.4%
Value ($000) $548 Shares 19,388 Est. Cost $28.26 Unrealized
AVEO PHARMACEUTICALS INC 0.2%
Value ($000) $337 Shares 149,073 Est. Cost $2.79 Unrealized
AVEO PHARMACEUTICALS INC 0.1%
Value ($000) $158 Shares 70,100 Est. Cost Unrealized